NIPBL: a new player in myeloid cell differentiation

Area of Science:

• Hematology
• Molecular Biology
• Cancer Research

Background:

• The nucleophosmin 1 (NPM1) gene is frequently mutated in acute myeloid leukemia (AML).
• NPM1 mutations often co-occur with mutations in cohesin genes, but not typically the cohesin regulator NIPBL.
• A specific reduction in NIPBL expression is observed in AML patients with NPM1 mutations.

Purpose of the Study:

• To investigate the role of NIPBL in hematopoiesis and its interaction with mutated NPM1.
• To explore the mechanism by which NPM1 mutations affect NIPBL expression and myeloid differentiation.
• To identify potential therapeutic targets by understanding the NIPBL/NPM1 interplay in AML.

Main Methods:

• Analysis of NIPBL expression in adult AML patients with NPM1 mutations.
• Generation of a zebrafish model overexpressing mutated NPM1 to study NIPBL regulation.
• Creation of a zebrafish model with NIPBL downregulation to assess hematopoietic effects.
• Investigation of the canonical Wnt pathway activation and rescue strategies.

Main Results:

• Overexpression of mutated NPM1 in zebrafish downregulated the NIPBL ortholog, nipblb.
• NIPBL downregulation in zebrafish led to an increased number of myeloid progenitors.
• This phenotype was linked to hyper-activation of the canonical Wnt pathway.
• Inhibition of the Wnt pathway rescued the myeloid progenitor expansion.

Conclusions:

• NIPBL plays a crucial role in zebrafish hematopoiesis.
• An interplay between NIPBL and NPM1 regulates myeloid differentiation via the canonical Wnt pathway.
• Dysregulation of the NIPBL/NPM1 interaction contributes to leukemic transformation in AML.